期刊文献+

PD-L1在皮肤鳞状细胞癌及角化棘皮瘤中的表达 被引量:3

The expression of PD-L1 level in cutaneous squamous cell carcinoma and keratoacanthoma
下载PDF
导出
摘要 目的:检测PD-L1在皮肤鳞状细胞癌(cSCC)及角化棘皮瘤(KA)中的表达,分析PD-L1与cSCC分化程度的相关性。方法:免疫组化染色检测PD-L1在cSCC及KA中表达水平。结果:共检测56例cSCC患者和32例KA患者标本,PD-L1在cSCC组和KA组中的阳性率分别为66.07%和62.50%,均显著高于正常对照组(9.38%)(P s<0.01)。PD-L1阳性率在cSCC与KA组的差异没有统计学意义(P>0.05)。PD-L1的表达强度与cSCC的分化程度呈负相关(P<0.05)。结论:PD-L1不能作为区分cSCC与KA的指标。PD-L1的表达强度与cSCC分化程度呈负相关。 Objective:To detect the level of PD-L1 in the patients with cutaneous squamous cell carcinoma(cSCC)and keratoacanthoma(KA),and to analyze the correlation between PD-L1 and the differentiation of cSCC.Methods:The expression level of PD-L1 in the lesions of cSCC and KA was detected by immunohistochemical staining.Results:Fifty-six patients with cSCC and 32 patients with KA were collected.The positivity rates of PD-L1 in cSCC patients were 66.07% and 62.50% in KA patients,which was significantly higher than that in controls(9.38%)(P s<0.01).There was no significant difference in the positivity rate of PD-L1 between cSCC and KA patients(P>0.05).The level of PD-L1 was negatively correlated with the differentiation degree of cSCC(P<0.05).Conclusion:PD-L1 may not be a useful indicator for the differnece between cSCC and KA.The level of PD-L1 was negatively correlated with the differentiation degree of cSCC.
作者 胡婕 陈伟 卢平 程双华 李灿 HU Jie;CHEN Wei;LU Ping;CHENG Shuanghua;LI Can(Department of Pathology,The Second Affiliated Hospital of Chengdu Medical College,National Nuclear Corporation of 416 Hospital,Chengdu 610051,China)
出处 《中国麻风皮肤病杂志》 2020年第6期335-338,共4页 China Journal of Leprosy and Skin Diseases
基金 成都市卫生和计划生育委员会科研课题(编号:2018070)。
关键词 皮肤鳞状细胞癌 角化棘皮瘤 程序性死亡因子配体-1 cutaneous squamous cell carcinoma keratoacanthoma programmed death factor ligand-1
  • 相关文献

参考文献4

二级参考文献22

  • 1Chu DH, Hale EK, Robins P. Generalized eruptive keratoacanthoma of grzybowski. J Drugs Dermatol 2003;3:318-319. 被引量:1
  • 2Mangas C, Bielsa I, Ribera M, et al. A case of multiple keratoacanthoma centrifugum marginatum. Dermatol Surg 2034;30:803-806. 被引量:1
  • 3Cribier B, asch P-H, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria: is it possible? A study of 396 cases. Dermatology 1999;199:208-212. 被引量:1
  • 4Biesterfeld S, Josef J. Differential diagnqsis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry. Anticancer Res 2002;22:3019-3023. 被引量:1
  • 5Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM(CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol 2003; 16:8-13. 被引量:1
  • 6Tran T-A, Ross JS, Sheehan CE, et al. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Mod Pathol 2000;12:427-432. 被引量:1
  • 7Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001;158:1633-1637. 被引量:1
  • 8Mukunyadzi P, Sanderson RD, Fan C-Y, et al. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma. ModPathol 2002;15:45-49. 被引量:1
  • 9Machin P, Catasus L, Pons C, et al. Microsatellite instability and immuneostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torte syndrome. J Cutan Pathol 2002;29:415-420. 被引量:1
  • 10Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol 2001;42:168-171. 被引量:1

共引文献71

同被引文献26

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部